Anna Alperovich, MD, is a hematologist-oncologist at the Division of Hematology and Medical Oncology at Weill Cornell Medicine/NewYork-Presbyterian Hospital where she cares for patients with blood cancers who are in need of astem cell transplant or cellular therapy.Specializing in treating patients with a wide range of blood cancers, including lymphomas, leukemias and bone marrow failures, Dr. Alperovich uses bone marrow transplantation with autologous stem cells—in which immature, healthy cells are taken from the patient and given back after chemotherapy—orallogeneic stem cells, which come from a genetically matched donor. She also uses chimeric antigen receptor (CAR) T-cell therapy, an innovative cellular therapy-based treatment in which immune system cells called T-cells are altered in a laboratory and re-infused into the patient to fight their blood cancer.Dr. Alperovich received her medical degree from the University of Grenada in the West Indies in 2012. She completed her residency at New York University, hematology and medical oncology fellowship at Maimonides Medical Center in Brooklyn, and specialized training in Bone Marrow Transplant at Memorial Sloan Kettering Cancer Center in New York. Prior to this position, Dr. Alperovich worked as a stem cell transplant physician at Northwell Health.Dr. Alperovich is an assistant professor at Weill Cornell Medicine and assistant attending at NewYork-Presbyterian Hospital. She is fluent in both English and Russian. Dr. Alperovich has published numerous research articles in peer-reviewed medical journals, with a focus on hematologic malignancies. She is a member of the American Society for Transplantation and Cellular Therapy (ASTCT). She is also a recipient of an American Society of Hematology (ASH) abstract achievement award.
Partial Data by Infogroup (c) 2024. All rights reserved.
